Abstract
The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.
Original language | English (US) |
---|---|
Pages (from-to) | 203-222 |
Number of pages | 20 |
Journal | Controlled Clinical Trials |
Volume | 25 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2004 |
Keywords
- Chemoprevention
- Finasteride
- Prostate cancer
- Study management
- Study organization
ASJC Scopus subject areas
- Pharmacology